Probiotics in the add-on treatment of otitis media in clinical practice

Otitis media (OM) affects the middle ear and is typically characterized by earache. OM may be classified as acute (AOM) or chronic (COM), based on symptom duration. OM may be clinically suspected, but the diagnosis is usually confirmed by the otoscopy. Antibiotic therapy is frequently used in clinic...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of biological regulators and homeostatic agents Vol. 34; no. 6 Suppl. 1; p. 19
Main Authors:	Gelardi, M, La Mantia, I, Drago, L, Meroni, G, Aragona, S E, Cupido, G, Vicini, C, Berardi, C, Ciprandi, G
Format:	Journal Article
Language:	English
Published:	Italy 01-11-2020
Subjects:	Anti-Bacterial Agents - therapeutic use Dysbiosis - drug therapy Humans Lactobacillus Otitis Media - drug therapy Probiotics acute antibiotic therapy otitis media chronic dysbiosis probiotics
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Otitis media (OM) affects the middle ear and is typically characterized by earache. OM may be classified as acute (AOM) or chronic (COM), based on symptom duration. OM may be clinically suspected, but the diagnosis is usually confirmed by the otoscopy. Antibiotic therapy is frequently used in clinical practice. However, antibiotics often induce intestinal and respiratory dysbiosis associated with some clinical problems. A one-month course of a probiotic mixture (Abincol® containing Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 million living cells), and Lactobacillus delbrueckii LDD01 (200 million living cells), was prescribed in the Group A, and was compared with no addon treatment, such as the Group B. Patients were evaluated at baseline (T0), at the end of antibiotic treatment (T1), at the end of probiotic course (T2), and at the end of 3-month follow-up (T3).
ISSN:	0393-974X